These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
877 related articles for article (PubMed ID: 9815541)
1. Prostate-specific membrane antigen expression in normal and malignant human tissues. Silver DA; Pellicer I; Fair WR; Heston WD; Cordon-Cardo C Clin Cancer Res; 1997 Jan; 3(1):81-5. PubMed ID: 9815541 [TBL] [Abstract][Full Text] [Related]
2. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Chang SS; Reuter VE; Heston WD; Bander NH; Grauer LS; Gaudin PB Cancer Res; 1999 Jul; 59(13):3192-8. PubMed ID: 10397265 [TBL] [Abstract][Full Text] [Related]
4. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients. Schmittgen TD; Teske S; Vessella RL; True LD; Zakrajsek BA Int J Cancer; 2003 Nov; 107(2):323-9. PubMed ID: 12949815 [TBL] [Abstract][Full Text] [Related]
5. Prostate-specific membrane antigen is produced in tumor-associated neovasculature. Chang SS; O'Keefe DS; Bacich DJ; Reuter VE; Heston WD; Gaudin PB Clin Cancer Res; 1999 Oct; 5(10):2674-81. PubMed ID: 10537328 [TBL] [Abstract][Full Text] [Related]
6. Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer. Ananias HJ; van den Heuvel MC; Helfrich W; de Jong IJ Prostate; 2009 Jul; 69(10):1101-8. PubMed ID: 19343734 [TBL] [Abstract][Full Text] [Related]
7. Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer. Ross JS; Sheehan CE; Fisher HA; Kaufman RP; Kaur P; Gray K; Webb I; Gray GS; Mosher R; Kallakury BV Clin Cancer Res; 2003 Dec; 9(17):6357-62. PubMed ID: 14695135 [TBL] [Abstract][Full Text] [Related]
8. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. Wernicke AG; Varma S; Greenwood EA; Christos PJ; Chao KS; Liu H; Bander NH; Shin SJ APMIS; 2014 Jun; 122(6):482-9. PubMed ID: 24304465 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder. Lane Z; Hansel DE; Epstein JI Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358 [TBL] [Abstract][Full Text] [Related]
10. Short term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane antigen expression in prostate tissues. Chang SS; Reuter VE; Heston WD; Hutchinson B; Grauer LS; Gaudin PB Cancer; 2000 Jan; 88(2):407-15. PubMed ID: 10640975 [TBL] [Abstract][Full Text] [Related]
11. Comparison of anti-prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma. Chang SS; Reuter VE; Heston WD; Gaudin PB Urology; 2001 Jun; 57(6):1179-83. PubMed ID: 11377343 [TBL] [Abstract][Full Text] [Related]
12. The clinical role of prostate-specific membrane antigen (PSMA). Chang SS; Heston WD Urol Oncol; 2002; 7(1):7-12. PubMed ID: 12474535 [TBL] [Abstract][Full Text] [Related]
13. Expression pattern of mouse homolog of prostate-specific membrane antigen (FOLH1) in the transgenic adenocarcinoma of the mouse prostate model. Schmittgen TD; Zakrajsek BA; Hill RE; Liu Q; Reeves JJ; Axford PD; Singer MJ; Reed MW Prostate; 2003 Jun; 55(4):308-16. PubMed ID: 12712410 [TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis. Mannweiler S; Amersdorfer P; Trajanoski S; Terrett JA; King D; Mehes G Pathol Oncol Res; 2009 Jun; 15(2):167-72. PubMed ID: 18802790 [TBL] [Abstract][Full Text] [Related]
16. Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique. Mhawech-Fauceglia P; Zhang S; Terracciano L; Sauter G; Chadhuri A; Herrmann FR; Penetrante R Histopathology; 2007 Mar; 50(4):472-83. PubMed ID: 17448023 [TBL] [Abstract][Full Text] [Related]
17. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models. Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223 [TBL] [Abstract][Full Text] [Related]
18. Prostate-specific Membrane Antigen (PSMA) Expression in the Neovasculature of Gynecologic Malignancies: Implications for PSMA-targeted Therapy. Wernicke AG; Kim S; Liu H; Bander NH; Pirog EC Appl Immunohistochem Mol Morphol; 2017 Apr; 25(4):271-276. PubMed ID: 26862945 [TBL] [Abstract][Full Text] [Related]
19. Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies. Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Ben Rais N; Ouertani L; Nouira Y; Horchani A; Oueslati R J Exp Clin Cancer Res; 2010 Dec; 29(1):171. PubMed ID: 21189143 [TBL] [Abstract][Full Text] [Related]
20. Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers. Haffner MC; Kronberger IE; Ross JS; Sheehan CE; Zitt M; Mühlmann G; Ofner D; Zelger B; Ensinger C; Yang XJ; Geley S; Margreiter R; Bander NH Hum Pathol; 2009 Dec; 40(12):1754-61. PubMed ID: 19716160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]